Navigation Links
Palatin Technologies and King Pharmaceuticals Announce Plan To,Present Results of Bremelanotide Phase 2b Studies in Men With,Erectile Dysfunction

t ED

ED is defined as the consistent inability to attain and maintain an erection sufficient for sexual intercourse. The condition is correlated with increasing age, cardiovascular disease, hypertension, diabetes, hyperlipidemia, and smoking. In addition, certain prescription drugs and psychogenic issues may contribute to ED. It is estimated that some degree of ED affects one half of all men over the age of 40 and that 150 million men worldwide suffer from ED.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. Palatin's lead product candidate, bremelanotide, is currently in Phase 2 clinical trials for both male and female sexual dysfunction. Palatin's internal research and development capabilities, anchored by its proprietary MIDAS(TM) technology, are fueling product development. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. To date, Palatin has entered into collaborations with AstraZeneca, King Pharmaceuticals, and Tyco Healthcare Mallinckrodt. For additional information regarding Palatin, please visit Palatin Technologies' website at http://www.palatin.com.

About King Pharmaceuticals, Inc.

King, headquartered in Bristol, Tennessee, is a vertically integrated branded pharmaceutical company. King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products in attractive markets and the strategic acquisition of branded products that can benefit from focused promotion and marketing and product life-cycle management.

Forward-looking Statements

<
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Palatin Technologies and King Pharmaceuticals Report Data Showing Improvements in Sexual Relationship and Self-Esteem in Patients with Erectile Dysfunction Treated with Bremelanotide
2. Neose Technologies to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
3. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals
4. Genelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV Polymerase Inhibitor at 20th International Conference on Antiviral Research Meeting
5. Micell Technologies Presents Data on Novel Drug-Eluting Stents
6. OncoGenex Technologies Announces Phase II Data of OGX-011 in Metastatic Breast Cancer at American Association for Cancer Research 2007 Annual Meeting
7. AVAX Technologies Presents Results of Phase I-II M-Vax Trial at Annual Meeting of American Association for Cancer Research
8. Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
9. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:7/28/2014)... July 28, 2014 Reportbuyer.com has added a ... Densitometers Market 2014-2018 https://www.reportbuyer.com/product/2225723/Global-Bone-Densitometers-Market-2014-2018.html ... scan is a special type of X-ray test used ... is used primarily to detect osteopenia or osteoporosis, diseases ... risk of fractures is high. The purpose of bone ...
(Date:7/28/2014)... , July 28, 2014 Reportlinker.com announces ... in its catalogue: Portugal Pharmaceuticals ... http://www.reportlinker.com/p0207141/Portugal-Pharmaceuticals-and-Healthcare-Report-Q3-2014.html Includes ... View: Faster-than-expected economic growth last quarter has led ... slightly upwards. As forecast previously, BMI expects ...
(Date:7/28/2014)... NORWALK, Conn. , July 28, 2014  UBM ... , a leading online community for medical imaging professionals, ... value in value-based payment models . The ... in identifying how the radiologist,s reimbursement is determined ... article features insight from leaders in the field, who ...
Breaking Medicine Technology:Global Bone Densitometers Market 2014-2018 2Global Bone Densitometers Market 2014-2018 3Global Bone Densitometers Market 2014-2018 4Global Bone Densitometers Market 2014-2018 5Portugal Pharmaceuticals and Healthcare Report Q3 2014 2Portugal Pharmaceuticals and Healthcare Report Q3 2014 3Portugal Pharmaceuticals and Healthcare Report Q3 2014 4Diagnostic Imaging Delves into Measuring the Radiologist's Value 2
... Calif., July 15, 2011 Amgen (NASDAQ: ... States (U.S.) District Court in Pennsylvania has entered ... Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA prohibiting ... G-CSF (granulocyte colony-stimulating factor) and methods for its ...
... EDISON, N.J., July 15, 2011 Crestor ... designed to lower "bad cholesterol". Both drugs are classified ... inhibiting HMG-CoA reductase. This group of drugs has had ... to Crestor and Zocor, touted as a "super statin" ...
Cached Medicine Technology:Amgen Resolves G-CSF Patent Litigation With Teva 2Crestor and Zocor Drugs Linked to Muscle Degeneration, Rhabdomyolysis 2
(Date:7/29/2014)... The Multiple System Atrophy Coalition, a ... appointment of five new members to its Board of ... election of its executive directors. The MSA Coalition ... 2 Physician Advisors. These 12 dedicated volunteers are ... education, support, advocacy and research funding for the neurological ...
(Date:7/29/2014)... 2014 A Forever Recovery , an ... to a great start and gives them a solid foundation ... of the National Cherry Festival kickoff concert held on July ... was co-sponsored by Miller Lite and in partnership with WKLT ... Bay Side Music Stage presented by Blue Cross Blue Shield ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Nuanced Media, ... are now a HIPAA (Health Insurance Portability and Accountability ... for protecting the storage and transfer of Personal Health ... services compliant, Nuanced Media can effectively serve their ... allows the agency to offer medical industry specific products ...
(Date:7/29/2014)... The Marietta cosmetic dentists at Verde Pointe ... high school and college students heading back to school during ... a safe, professional strength system, as the Marietta dentists believe ... these important stages in life. , Many students have gone ... teeth whitened. "After braces, teeth can be straight without ...
(Date:7/28/2014)... red blood cell development have spread from Africa into ... a new study led by King,s College London. The ... look for the origin of changes in a key ... Fetal haemoglobin is normally found in fetuses and infants, ... able to keep making it as adults experience milder ...
Breaking Medicine News(10 mins):Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 2Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 3Health News:The Multiple System Atrophy Coalition Appoints Five New Members to Board of Directors 4Health News:A Forever Recovery Sponsors National Cherry Festival Kickoff Concert Featuring Collective Soul on July 5 in Traverse City, MI 2Health News:Nuanced Media Web Design Agency Now Hipaa Certified 2Health News:Back to School Teeth Whitening Extravaganza For High School Students and Collegiates During August 2014 2Health News:Back to School Teeth Whitening Extravaganza For High School Students and Collegiates During August 2014 3Health News:Study tracks worldwide spread of beneficial blood cell gene variant 2Health News:Study tracks worldwide spread of beneficial blood cell gene variant 3
... DOMA Vector and DOMA Technologies to provide Record Conversion Services to more ... the Pacific. DOMA will convert millions of veteran treatment records from ... service to our veterans while reducing cost. , ... Virginia Beach, Va. ...
... DIEGO, May 7 Brandes Investment Partners, L.P. ("Brandes") ... submitted to Mitsui Sumitomo Insurance Group Holdings, Inc. (the ... on the Tokyo Stock Exchange, a proposal for a ... at the Company,s upcoming annual meeting of shareholders. ...
... weathering recession at national ALFA conferencePHILADELPHIA , ... executives today expressed confidence in the state of ... the conclusion of a national conference here.The executives ... far better than other businesses because it had ...
... Mobilization Campaign Urges Congress to Make Health Reform Work ... Hospital at Stanford is joining the National ... to launch a grassroots mobilization campaign asking Congress and ... for children. "Our hospital is extraordinarily proud ...
... WASHINGTON, May 7 The following is ... of the American Health Care Association (AHCA), Dave Kyllo, ... (NCAL) and Alan G. Rosenbloom, President of the Alliance ... the Obama Administration,s commitment to creating new jobs and ...
... May 7 Acting in response to concerns about ... Hotels and Resorts (TM), a privately held operator ... North America and Europe, today announced a three-phase program ... and provide reassurance about the safety of its facilities.(logo: ...
Cached Medicine News:Health News:Veterans Administration Awards Small Business' $13 Million Contract to Digitize Veterans Health Records 2Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 2Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 3Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 4Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 5Health News:Brandes Proposes 40 yen Per Share Dividend for Mitsui Sumitomo Insurance Group Holdings, Inc. Annual Meeting 6Health News:Senior Living Executives Optimistic About Future 2Health News:Lucile Packard Children's Hospital at Stanford to Raise Its Voice for Kids in Health Care Reform Debate 2Health News:Lucile Packard Children's Hospital at Stanford to Raise Its Voice for Kids in Health Care Reform Debate 3Health News:Joint Statement from AHCA, NCAL, and the Alliance on the Obama Administration's FY 2010 Budget 2Health News:Dolce Hotels and Resorts Initiates Program to Mitigate H1N1 Flu Risk 2
The Biopro Cox comb cup is manufactured from titanium and is porous coated on the outside of the shell. The Cox comb cup accommodates a polyethylene insert....
The Plasmacup SC satisfies two important requirements: high primary stability and a low friction bearing surface....
... The integration of Trabecular Metal ... proven implant design results in a ... not only meets surgeon demands for ... provides a wide variety of shell ...
The cementless BiHAPro cup combines proven concepts with the latest innovations in cementless THR....
Medicine Products: